PR

TACO_Orange_3098

Well i think the actual mortgage docs Reuters saw that showed she listed her property as a vacation home and not a PR is also telling :D

Plus_Promotion_9510

What’s the best bets. Drop the tickers. I’m tryna leave my wife and go to PR and bring back a big booty latina home

Boston-Bets

"and even create greater miracles for the market. " Killer. I was willing to entertain the possibility that there might be something there with this stock, but reading that PR and specially that line... RUN AWAY

Stellar_Impulse

NFE is so far down, that it moves solely on any news regarding its PR contracts. Since they're in cahoots with the local admin, I knew it was just a matter of time til they announced something and I bet theres more coming down the road.

Consistent-Sun5188

Motley Fool highlighting Archer’s $1.7B cash pile is the real story here. In a space where everyone’s bleeding cash, having that much runway matters more than flashy PR. The Georgia plant and LA28 partnership aren’t just nice headlines  they’re proof Archer is locking in long term infrastructure that competitors can’t replicate overnight

astrasjt

Wes Edens. He’s just an amazing person. And I cannot believe he would accept failure — ever. Point in case: NFE just pulled off a contract with PR (finally). I’m still in the red by A LOT, but I’m going to ride it out for the meantime.

EnvironmentalSoft343

Im in $RELI and $SVRE this morning. Both Low Float, currently I am down a bit because I bought at highs (should have waited for dips). I am banking on Fed Rate Cute (2:00 PM EST) to get a Crypto run this afternoon. $RELI Catalyst: PR this morning about an Ethereum treasury $SVRE Vibes: Loads of Volume pre-market today. Don't know why, but I've thrown in money just in case.

AntoniaFauci

Former nuclear scientist here. Your headline is correct that uranium is in a supply crunch. However the body of your post is wrong where it claims rising demand. Also the parts where you tout advantages and progress, that’s actually just typically false propaganda from nuclear industry lobbyists and PR. Demand is flat. And there are zero nuclear plants under construction here, and zero approved for construction. The nuclear energy pitch from their aggressive and increasingly feverish lobby and marketing agencies has numerous fatal flaws. It’s a very long story how it can be that demand is flat but supply is deeply short. The simplest explanation is that consumers have let their inventories deplete, and producers/refiners have limited their output. People outside the industry hear a lot of nuclear chatter and don’t realize that much of that on social media (especially Reddit) is generated by agencies turfing, then exploiting a particular demographic for crowd source promotion. And people outside the industry would see this social media hype, connect the dots to rising demand for electricity and assume that means uranium demand and consumption have changed. They haven’t. And they can’t change meaningfully for decades, since that’s how long and theoretical plant builds take. That said, my investment is though uranium itself, not the various super-speculative and over-hyped reactor proposal stocks. In short, that’s because I know on a factual level the supply crunch is true. But with the reactor stock promoters, their premise is 100% speculative. And a lot of what they say about the technology is untrue, so why would we believe what they say about the economics?

BmoneyD

Thinking about how that very first after hours news release of “US and China agree to a trade deal” with that little PR release on the WH website caused my $300k spy call position that I bought right before market closed to be -85% by the next morning market open. And it was all for nothing because that news was fake.

Solid_Jackfruit_2932

I’m clearly a pumping bot when I told them people to get out of PRPH as soon as PR came out and it indeed tanked since. The classic old “you’re a bot” when someone isn’t shilling everything and being realistic.

RaZE___SoViEt

**$OPEN** (In this one) - Rate cuts Sep 19. **$DVLT** (in this at 0.35cb) , will exit In PM. At 0.55 overnight, would not enter at this levels, unless running. **PM Watchlist** : **$NFE** (Discord) : high short, big PR running. **$SVRE** : low float big volume. ___ DO NOT HOLD THIS: ☠️ risky short PM: **$NITO** RS dead cat bounce. 🇨🇳: **$YASS** , **$ORIS** in both for swings. Always do your own DD. NFA.

Get_rch_or_try_dyin

I held for like 8 months , but the company never seemed to announce much, and they don’t have much PR or anything. But I hope it rips

TimmyTee93

Deal isn’t quite finalized yet still needs to be approved by the oversight board. They did lose a bigger and longer deal with PR already due to this.

SignificanceLate7002

Most of the volume seems to have been controlled through darkpool volume the last two days. %70 yesterday and %55-60 today. Several very large accumulation type exchanges were made each day. It seems to be intentional price control for some reason. I personally believe the big players, MMs, were shaking out retail holders and also giving shorts a window to exit. It makes sense with the massive squeeze building up as options expire at the end of the week. I expect the shorts that didn't take the opportunity to exit today to attempt to run this down again tomorrow, but they may have missed the opportunity. Darkpool players will likely keep the price locked in the $5-6 range with some PR coming out before Friday and then let her fly. These are just my thoughts and I could be completely wrong here. Use your own judgment on this one.

Worldly_Marketing665

Solid angle. The same playbook applies in housing finance… capacity shifts always create asymmetric moves. Datacenters can’t be built fast enough, just like secondary mortgage liquidity can’t instantly expand when rates move. The winners are the ones positioned before the herd, not chasing the contracts after the PR hits

ralphy112

Trump believes that his policies are going to look oretty bad short term, and that’s bad PR for him and his behavior. And probably for midterm election favorability. If he’s not eyeing 2025, he’s planning to cause plenty more chaos in 2026 and if he’s can avoid an earnings report for 5 months before midterms that’s a biggie. And he just hopes companies and people somehow forget his behavior by the 5.5 month point after he really does something crazy. This has nothing to do with companies being able to focus more obviously.

slinkboss22

Ya that’s a mess. They have a partnership with Airstream and even that PR was botched I feel like

Great_Molasses_4601

I feel that every day with DFLI, they have amazing products; and about to start making profit with patents actively being approved. Their PR team just isnt active in the sense that like Ondas's is, and I hate how much Hype decides a good stock over its background.

Fit_Dimension9564

United CFO is on record saying this can reshape urban transport. That’s corporate commitment, not just PR. Add in DOT/FAA involvement, and this is starting to look like the early framework for U.S. adoption at scale

Mundane-Warning-4309

$ADAP: analysis of a potential BOOM Adaptimmune Therapeutics plc (NASDAQ: ADAP) — Analysis (as of 16 Sep 2025) 1) Snapshot (one-pager) • What it does: Cell-therapy biotech focused on engineered T-cell receptor (TCR-T) therapies for solid tumors. First product TECELRA® (afamitresgene autoleucel) received U.S. FDA accelerated approval for unresectable/metastatic synovial sarcoma in HLA-A*02-positive adults (Aug 2, 2024). • 2025 reset: Q2’25 TECELRA sales $11.1M (16 patients invoiced; >150% vs Q1) and a definitive deal to sell TECELRA plus lete-cel, afami-cel and uza-cel to US WorldMeds for $55M upfront + up to $30M milestones; USWM to continue lete-cel and uza-cel development. • Balance sheet pressure: Cash $26.1M at 30-Jun-2025, negative equity $71.0M, H1 net loss $77.9M; “substantial doubt” going-concern flagged in 10-Q. Top takeaways • Validation: First engineered cell therapy approved for a solid tumor in the U.S. (category-defining). • Strategic pivot: Portfolio sale to USWM trades near-term cash relief for future upside via milestones/royalty-like economics. • Financial risk remains high pending cash-in timings, cost cuts and any new deals. ⸻ 2) Business model & product set • Platform: Autologous TCR-T targeting tumor antigens (e.g., MAGE-A4); pipeline materials point to PRAME and CD70 programs in preclinical/allogeneic exploration. • Commercial path: Initially self-commercialized TECELRA (centers onboarding, companion Dx), now handed to USWM to scale; Adaptimmune positions itself to focus spend and potentially harvest milestones. ⸻ 3) Financial performance (last 3Y / recent quarters) • Launch metrics: Q2’25 TECELRA product revenue $11.1M (16 invoiced). Company highlighted >150% q/q growth vs Q1. • Profitability & cash burn: H1’25 net loss $77.9M; operating cash use $101.4M; cash $26.1M at 30-Jun. • Consensus beat (context): External roundup notes Q2 revenue and EPS beat (EPS −$0.02 vs −$0.05 est.). ⸻ 4) Latest results & guidance color • Q2’25 PR highlights: accelerating invoiced patients, USWM sale to de-risk operations and extinguish Hercules debt obligations as part of the restructuring steps. • Regulatory designations: Lete-cel granted Breakthrough Therapy (Jan 2025), now stewarded by USWM. ⸻ 5) Liquidity, runway & capital structure • GAAP view: 10-Q explicitly states substantial doubt about going concern within 12 months from issuance; cash $26.1M, no marketable securities, negative equity $71.0M at 30-Jun-2025. • Offsetting items: $55M upfront from USWM + potential milestones; management’s forward-looking statements suggest using proceeds plus opex cuts to extend runway, but execution/timing is key. ⸻ 6) Valuation context (qualitative) • Equity reflects binary-style risk typical of small-cap biotech in transition: commercial proof-points vs. balance-sheet stress. Street takes vary, hinging on TECELRA uptake under USWM and any business-development. (Use live price/multiples when making a trading decision.) ⸻ 7) Stock & trading color • Drivers: FDA approval (Aug 2024), launch ramp headlines, portfolio sale (Jul 2025), and ongoing restructuring. Expect high volatility around cash updates, patient throughput, and milestone events. ⸻ 8) Ownership — institutions & insiders • Notable holders (mid-2025 13F snapshots): Long Focus Capital, Two Seas Capital, NEA, EcoR1, MPM among others; institutional ownership ~low-to-mid 30%s per trackers. • Recent changes: Select funds increased or trimmed positions through H1’25; monitor 13F updates for trend confirmation. ⸻ 9) Competitive landscape (TCR / solid-tumor cell therapy) • Immunocore (IMCR): TCR-based (ImmTACs); commercial tebentafusp (melanoma) — closest tech validation peer. • Takara Bio: TCR-T efforts incl. synovial-sarcoma targets; overlaps in indications/biology. • TScan Therapeutics (TCR discovery/target ID) and other emerging TCR players (e.g., Lion TCR, Medigene) populate the watchlist. ⸻ 10) Catalysts (3–12 months) • USWM execution: Center activation, patient access, payer traction and confirmatory trial progress for TECELRA (post-accelerated approval). • Milestone triggers: Commercial/clinical milestones payable by USWM. • Restructuring progress: Opex cuts, workforce transitions (USWM absorbing ~half; ADAP further reductions) and any new partnerships. ⸻ 11) Key risks • Liquidity/dilution risk if cash receipts and cost actions don’t bridge to sustainable inflows; going-concern warning underscores urgency. • Commercial risk: TECELRA’s niche, HLA-restricted label and rare-disease footprint could cap peak sales; payer dynamics and center throughput matter. • Pipeline optionality reduced by the USWM sale (near-term cash vs. long-term in-house assets). ⸻ 12) Sentiment & social (incl. Reddit, last 30–60 days) • Tone: Mixed-negative to moderately optimistic — bulls cite first-in-class approval/undervaluation; bears stress liquidity/dilution and narrow indication. Activity clusters in risk-tolerant subs (e.g., r/pennystocks, r/biotech). ⸻ 13) Scenarios & thesis • Bull: USWM scales TECELRA faster than expected; early milestones arrive; ADAP stabilizes opex and secures partner funding — equity re-rates on durability. • Base: Gradual uptake; ADAP relies on milestones/BD to extend runway; stock tracks execution updates. • Bear: Slow uptake or delayed cash inflows; additional financing at unfavorable terms; going-concern overhang persists. ⸻ 14) Executive conclusion (10 lines) 1. Clinical validation is real (FDA approval), a rare feat in solid-tumor cell therapy. 2. Strategic sale to USWM swaps capital intensity for near-term liquidity and milestone economics. 3. Q2’25 showed uptake (16 patients; $11.1M sales), but base remains small. 4. Balance-sheet strain is the core investment risk (cash $26.1M; going-concern). 5. Restructuring/opex cuts and debt actions are necessary but not sufficient. 6. Milestone timing from USWM is the swing factor near term. 7. Pipeline breadth narrows post-sale; optionality shifts to partners. 8. Competitive bar in TCR remains high (Immunocore et al.). 9. Sentiment is speculative and headline-driven. 10. Risk/reward hinges on USWM execution + cash runway stabilization over the next 2–4 quarters.

SignificanceLate7002

Keep an eye on it. There's still potential for a squeeze. Options expire Friday with the majority of strikes in the 6.50 tp 7.50 range. SI is extremely high with over %800 CTB. Some brokers increased margin rates to %500 and there's still zero shares available to borrow. Darkpool activity seemed to be working to hold the price between $6.10 and $6.50 and accounted for %70 of total volume. This seems to be intentional. If any PR comes out or starts to trend up it could set off a major short squeeze.

wlburgos

We need to hold strong. At least until end of week. This contract need to be close ASAP. Both the PR Government and NFE need this deal now. This should bomp the stock enough to a decent revenue

theruzki

they went back on it, their tweets right after just point to a PR stunt just so people get reminded of their existence

Clear_Anything1232

You can see my comment history. I have been advocating for this stock since it was in the 190s. In fact when I entered, I could genuinely not understand why it was so undervalued. I work in tech and use these models, clouds, apps, services on a day to day basis. Don't fall for Sam Altman's PR. GPT5 has been a disaster across the board. If anyone can figure out how to add ads to loss leaders, that's Google. But anyways none of this is why I'm bullish on the stock. That is purely because of their lowering of cost structure during the last 2 years of layoffs and new nimble way of product development (notebookllm, nano banana, opal). These guys are going back to their roots of rapid product releases and not worried about producing duds. I'm optimistic about this new pumped up Google. They no longer care about their brand name and this time it's a good thing.

Aggravating-Fig2692

CJMB is a small Texas logistics firm in the cold chain space, where the market's growing at about 13-15% CAGR from $300-400B today to over $1T by the 2030s. Their CEO, Wayne Williams, brings serious government cred as the former Associate Director of Logistics for the Strategic National Stockpile, helping with post-9/11 expansions and still advising federal programs. Insiders own around 70% of the company, showing they're deeply invested in its success. For API onshoring, they've launched an India subsidiary with a Pune warehouse to import critical ingredients and tissue samples, bridging to U.S. manufacturing while keeping everything compliant. The Revival Health JV taps into that by handling wellness products sourced from South Korea APIs, opening new revenue in the longevity boom. Their proprietary Sentry platform (advanced real-time monitoring) and sustainable reusable shippers (with SHIP2Q sanitization) give them an edge in eco-friendly tech. Plus, food's a whole new growth area—expanding into premium packaging for gourmet samples and perishables, riding that 15% annual sector surge. With catalysts like gov contracts and this setup, it's worth checking out. UPS premier platinum is also a collaboration with callan. There is a email from UPS that confirms it yet no official PR yet. This company is 20m mcap right now...

PckMan

Indirectly. Sure it's good PR but at the end of the day it makes little difference to them.

nomadichedgehog

I don't have a crystal ball but you'd have to think it's a 5x minimum, adjusted for the RSS split, because I don't see how else the board could turn down a $3,60 offer only to have an RTO that only pushes the stock 2x. To give a numerical example, let's say we have an RSS announcement with a 10:1 ratio, that would push today's SP to $7.40 (but you'd have 1/10th of the shares you had before). For management to then justify rejecting the previous offer, they must have some expectation that the stock will surpass $37 in the days after the RTO is announced. I think my main concern at this point is how strong the Qumulus AI story will be post RTO announcement. Right now, they have a very limited footprint online with not much PR. I don't see how SONM board could have the confidence to reject $3,60 per share unless Qumulus AI has very strong fundamentals in the absence of good PR.

J_Dabson002

Yeah unfortunately it already got the bump from the good PR anything from now until the 29th is just speculation and that’s where the shorts thrive. I do expect it to be over $1 after the 29th though

J_Dabson002

Hate seeing people lose money or get caught bag holding Be careful chasing speculative PR. If there’s no current catalyst it’s usually a rug pull in the short term. So unless you can afford to hold shares for weeks do your DD.

linvoylegend

Sweet, SNAP announced an updated OS for glasses nobody gives a shit about. But they forgot to use "AI" in the press release, so obviously the Cracker Barrel PR team was involved

J_Dabson002

First batch of PR came out Still waiting on the details is the crypto treasury

_hiddenscout

Seems like it. Haven’t dug into the report yet. Just looked at the PR.  Usually do that after the gym and some more coffee.  Seems like a mixed result, with the good off setting the bad. 

Firm_Rich_8794

Google is the best one to play the AI risk reward game. Here's why: Alphabet is a holding company which has wide range of companies that command economies of scale be it Cloud, Youtube, Waymo, Deepmind, Search, Venture Capital, etc. The scale at which they operate gives them a clear advantage and that is to integrate AI into their products at a much lower cost than other LLM companies. They have the 5 billion customers and they can absorb the cost of integrating Gemini. They recently have started PR with nano banana which went viral. This PR strategy was missing and that again that feeds into the vicious cycle of their product use. Bear case is AI is a Fad which I don't believe so and even if you did give into that narrative, the fact that it can manage to improve its product suite and brush of the capex is clear win-win for Google. I'm long Google with 7% of total capital.

oquido

[https://www.gsk.com/en-gb/media/press-releases/gsk-and-spero-therapeutics-announce-exclusive-licence-agreement-for-tebipenem-hbr-a-late-stage-antibiotic-that-may-treat-complicated-urinary-tract-infections/](https://www.gsk.com/en-gb/media/press-releases/gsk-and-spero-therapeutics-announce-exclusive-licence-agreement-for-tebipenem-hbr-a-late-stage-antibiotic-that-may-treat-complicated-urinary-tract-infections/) GSK's PR on the licensing/partnership deal with SPRO Furthermore, GSK has recently received a FDA approval for uUTI antibiotics last year, and getting cUTI will complete their UTI portfolio.

SignificanceLate7002

Raze is on it. This is the one to get in early and hold on to. Extremely high SI. Merger confirmation PR was released late Friday AH. CTB is at %832 with zero shares available. Options expire EOW with loaded strikes. Schwab raised margin rates to %500. Lots of institutional holders. This is prime for a massive short squeeze.

RaZE___SoViEt

**$ASST** quick assessment I’ve made money here on initial run up on PR of the merger. NFA Watching this one Monday, was pushed down heavy after the news Friday AH. Currently halted for what I’m assuming ticket change and merger. Retail Hype is building up, will wait for confirmation before deciding to jump in, explosive set up if starts running. u/BeneficialSort9477 brought it up for quick DD. Big sell off walls at 10-12$ - unless climb is rapid. Up 90% on a 7 day in anticipation forming wedge, not an out of nowhere news. Was this priced in by big boys? **Short Float** and stats are insane ranging from **40%** on Finviz to —- **100%** **0** short shares left —— (FINTEL) **800%** borrow rates :eyes::bomb: [https://www.prnewswire.com/news-releases/strive-inc-announces-completion-of-merger-between-asset-entities-and-strive-enterprises-inc-302555443.html](https://www.prnewswire.com/news-releases/strive-inc-announces-completion-of-merger-between-asset-entities-and-strive-enterprises-inc-302555443.html) **$SEC** : [https://www.sec.gov/ix?doc=/Archives/edgar/data/0001920406/000121390025087278/ea0257129-8k\_strive.htm](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001920406/000121390025087278/ea0257129-8k_strive.htm) $ASST should have popped in AH big, with those insane stats on those kind of news. Reaction was mediocre to say it politely, but definitely Watchlist worthy for continuation. Might be big or get suppressed. IMHO halt is a bullish situation because it adds uncertainty and anticipation. Will enter on release. Also : https://preview.redd.it/t8vuacjn69pf1.jpeg?width=1284&format=pjpg&auto=webp&s=9ebb2760e9ad8848e83fc3b8f939137a0866b2a1

RaZE___SoViEt

**$ASST** quick assessment I’ve made money here on initial run up on PR of the merger. NFA Watching this one Monday, was pushed down heavy after the news Friday AH. Currently halted for what I’m assuming ticket change and merger. Retail Hype is building up, will wait for confirmation before deciding to jump in, explosive set up if starts running. u/BeneficialSort9477 brought it up for quick DD. Big sell off walls at 10-12$ - unless climb is rapid. Up 90% on a 7 day in anticipation forming wedge, not an out of nowhere news. Was this priced in by big boys? **Short Float** and stats are insane ranging from **40%** on Finviz to —- **100%** **0** short shares left —— (FINTEL) **800%** borrow rates :eyes::bomb: https://www.prnewswire.com/news-releases/strive-inc-announces-completion-of-merger-between-asset-entities-and-strive-enterprises-inc-302555443.html **$SEC** : https://www.sec.gov/ix?doc=/Archives/edgar/data/0001920406/000121390025087278/ea0257129-8k_strive.htm $ASST should have popped in AH big, with those insane stats on those kind of news. Reaction was mediocre to say it politely, but definitely Watchlist worthy for continuation. Might be big or get suppressed. IMHO halt is a bullish situation because it adds uncertainty and anticipation. Will enter on release.

KRAFT_MAY0

not a P&D, just got PR after an accumulation phase, will continue to rise leading up to 10-k filing on the 29th

FairAbbreviations749

Seriously, good PR or bad it shoots up. But I try not to cry too much as the casino since TSLA is volatile af.

Logical-Contest-4448

DD: Permian Resources ($PR) – Delaware Basin Pure-Play With Room To Run ⸻ Intro Permian Resources (ticker: PR) isn’t some random E&P chasing scattered acreage. They’re the largest pure-play operator in the Delaware Basin, which is the western half of the Permian Basin (West Texas + Southeast New Mexico). If you’ve followed shale at all, you know the Delaware is the crown jewel — some of the best rock in North America, stacked pay zones, great infrastructure, and tons of room to drill. PR has been growing into this position through smart acquisitions and strong operational execution, and right now they look set up to benefit from both scale and efficiency. ⸻ Why Care? 1. Acreage & Focus – Over 470,000 net acres in the Delaware Basin, all contiguous and in the “core of the core.” They don’t waste time on fringe plays. 2. Low Costs – They’ve been steadily bringing down lease operating expenses and drilling costs. That’s crucial in shale, because cost creep kills margins when oil dips. 3. Acquisition Game – PR just bought $600M worth of acreage and wells from APA in New Mexico. This wasn’t random land grab — it’s right next door to PR’s existing operations, meaning they can slot it in seamlessly. 4. Production Growth – That deal and ongoing development allowed PR to raise their 2025 oil production guidance to ~178,500 barrels per day. More oil, same infrastructure, same crews = more cash per dollar spent. 5. Shareholder Returns – Base dividend of $0.60 annually (~4% yield). They also buy back stock opportunistically when it trades cheap. ⸻ The APA Bolt-On This deserves its own section. In June, PR closed a deal with APA (Apache’s parent) to acquire ~13,000 net acres and ~12,000 barrels of daily production. Why it matters: • The acreage is directly next to PR’s current blocks in Lea and Eddy counties (New Mexico side of the Delaware). • Integration is straightforward — same crews, pads, and infrastructure. • Production bumps up right away, without them needing to drill new wells. Most acquisitions in shale destroy value because they’re expensive or far from your core. This one is the opposite: it’s accretive to cash flow and strengthens PR’s position as the top Delaware Basin operator. ⸻ Financial Health PR isn’t over-levered. Net debt is about 1x EBITDA, which is conservative compared to peers. They also just got an investment-grade rating, which lowers their cost of borrowing. That matters if oil gets volatile again — they won’t be forced into fire sales or equity raises. They’ve been printing solid free cash flow each quarter, even at mid-$60s oil. That means the base dividend is safe, and there’s room for buybacks and debt paydown. ⸻ Oil Price Sensitivity This isn’t magic — PR still lives and dies by oil prices. If WTI drops back into the 50s, free cash flow takes a hit. But because their acreage is in the Delaware core, they can survive downturns better than most peers. At $75 oil (a reasonable mid-cycle number), PR throws off well over a billion in free cash flow annually. Put another way: at today’s ~$14 stock price, the market is valuing them at a high single-digit free cash flow yield. If they just keep executing and oil holds steady, there’s a case for the stock in the $20 range over the next year or two. ⸻ Long-Term Bull Case • The Delaware Basin isn’t going away. It’s the most economic shale play in North America, and PR owns some of the best acreage in it. • They’ve proven they can integrate acquisitions without blowing up costs. The APA deal shows discipline. • Balance sheet is clean, dividend is covered, and management owns a big stake — they’re aligned. • As pipelines and marketing contracts shift more barrels to Gulf Coast pricing, PR should realize better netbacks (meaning higher prices per barrel compared to peers stuck in Waha discounts). ⸻ Risks • Oil price risk – obvious, and the biggest one. • Execution risk – if drilling or integration slips, costs can creep up fast. • Macro/regulation – federal regs in New Mexico or broader Permian could add headaches. ⸻ Bottom Line Permian Resources is one of the most compelling mid-cap E&Ps out there: pure Delaware Basin, low costs, smart acquisitions, shareholder-friendly capital returns, and a balance sheet that can handle oil price swings. At ~$14/share today, the market is pricing PR like a steady operator, not like a company that just grew production, raised guidance, and set itself up for higher netbacks in 2026. If oil stays anywhere in the $70–80 range, the math points to upside into the $20s, plus you’re paid a dividend while you wait. I’m long PR. Not financial advice, just sharing my DD.

ai-moderator

#TLDR --- **Ticker:** PR **Direction:** Up **Prognosis:** Long shares, collect the ~4% dividend while it runs to $20+ **The Gist:** Pure-play Delaware Basin operator with low costs, a clean balance sheet, and a habit of making smart, bolt-on acquisitions. The market hasn't fully priced in their growth, making it a compelling buy if oil stays above $70.

ai-moderator

#TLDR --- **Ticker:** PR **Direction:** Up **Prognosis:** Long shares for a run to the $20s, collect the ~4% dividend while you wait. **Why:** Largest pure-play operator in the Delaware Basin (the good stuff), making smart, cash-flow-positive acquisitions with a clean balance sheet. **Vibe:** Gushing free cash flow.

OddAdhesiveness6435

Strive will buy 75,000 BTC subject to share holder approval ASAP. Why? read the below... Strive targets 75,000 Bitcoin from Mt. Gox claims to build Bitcoin treasury. NOTE : Gov distribution Deadline is 31st Oct 2025. \>As shareholder approval will be needed before 31st Oct, the PR for this should come ASAP guys. [cointelegraph.com/news/stri...](https://stkt.co/7IkLCgtc) \> read the settlment .. Final Payment: This portion, which will provide the remaining balance of the claim (estimated to be about 15% after the intermediate payment), is scheduled to be paid out after the October 31, 2025, deadline. Now do you know how they will buy BTC and out perform BTC itself?

OddAdhesiveness6435

Strive will buy 75,000 BTC subject to share holder approval ASAP. Why? read the below... Strive targets 75,000 Bitcoin from Mt. Gox claims to build Bitcoin treasury. NOTE : Gov distribution Deadline is 31st Oct 2025. \>As shareholder approval will be needed before 31st Oct, the PR for this should come ASAP guys. [cointelegraph.com/news/stri...](https://stkt.co/7IkLCgtc) \> read the settlment .. Final Payment: This portion, which will provide the remaining balance of the claim (estimated to be about 15% after the intermediate payment), is scheduled to be paid out after the October 31, 2025, deadline. Now do you know how they will buy BTC and out perform BTC itself?

OddAdhesiveness6435

Strive will buy 75,000 BTC subject to share holder approval ASAP. Why? read the below... Strive targets 75,000 Bitcoin from Mt. Gox claims to build Bitcoin treasury. NOTE : Gov distribution Deadline is 31st Oct 2025. \>As shareholder approval will be needed before 31st Oct, the PR for this should come ASAP guys. [cointelegraph.com/news/stri...](https://stkt.co/7IkLCgtc) \> read the settlment .. Final Payment: This portion, which will provide the remaining balance of the claim (estimated to be about 15% after the intermediate payment), is scheduled to be paid out after the October 31, 2025, deadline. Now do you know how they will buy BTC and out perform BTC itself?

Nickeyblaze

Fair point. I didn’t exit the whole position. Only took profits because I’ve been on the gsat train for years only now we are at end game with new sats being launched and updated constellation. It’s an event based call option strategy. Many PR opportunities over the next 6 months so my plan is to constantly have OTM calls and roll forward. I just want them to start offering November calls. I have a pretty nice position in the actual shares which I don’t trade around. Call options are where I enjoy the trend up and pops. I’ll update this week :)

brennfl81

Here's my theory: CB's 14% selloff in a month isn't explained by fundamentals but rather public outrage. The company may have problems but the selloff was an overreaction driven by fear of and reaction to PR backlash rather than the fundamentals. Over the year it's still up significantly. PR backlash aside, and with their "we've learned the error of our ways and are going back to what you loved" approach, CB isn't going anywhere and the underlying fundamentals will govern again. And I suspect we'll see a bounce-back, either in the near-term or after ugly earnings from the backlash period cause a sell-off and then people move past it and get back to fundamental long-term analysis. But I'm a regard, so grain of salt.

FinestObligations

Clearly he did not write this, nor did he come up with this strategy. It’s a great PR move on his and Russias part, because he knows this will not happen so it makes Europe look weak.

30scaper30

AI retail and e-commerce. They're gaining a ton of momentum right now. They originally set 70m ARR guidance this year. They've confirmed they already hit that and fully expect to exceed 100m this year.  They moved up their earnings date to October 1st, likely a bullish sign. They've recently announced they've exceeded 10% institutional ownership. They have a growing list of customers, one of which is Target thanks to a recent acquisition. The CEO has been running good PR and expressing nothing but good news. Their CEO, among others, argue that their peers are trading at 36-100x ARR while RZLV currently trades around 17x, and they should be more in line with their peers in that regard.  Basically, it should be a solid long term hold and it has a lot of momentum moving into earnings. If you're thinking about buying now, consider how much it's gone up this last week, as all this good news could already be priced in and it's technically overbought right now. Many people think it should be trading $10+ currently though. Of course, do your own research. 

ShadowLiberal

He got the vaccine, but unlike other politicians such as Biden he didn't make a PR event of it by getting it on camera to show his own supporters that it was safe. And he chose a guy who's very clearly anti-vaccine to run the HHS.

Outrageous-Orange007

Apparently it is viable. Its just not going to be pretty. If you can destroy the value of the dollar and gut labor protection laws, America could bring back its manufacturing industry. It wouldn't be very competitive in the global market, and it would require workers which presumably will come from a loss of many managerial jobs, cut government jobs, PR employees(no need for them if companies aren't being held liable), artists(due to AI) and other jobs like tech jobs that AI will replace. As AI phases in people will lose their service based jobs(easier to replace) they will move to manufacturing. Then when AI moves to replacing the manufacturing jobs we will be largely self sufficient and able to move to a kind of UBI social credit system where the government is in complete control over your basic necessities

Imaginary_Stand73

It's literally how political messages get out. with money. the more money means the more you can spend on PR... bless your heart, boy.

Physical-Squirrel-40

EVAX I don’t understand why EVAX doesn’t get more attention. I STRONGLY encourage folks to take a look, do your diligence, and thank me later. EVAX is an AI-based biotech pharmaceutical company focused on utilizing AI to create new immunology vaccines. They have three vaccines in various stages of trials: EVX-01 (treatment of metastatic melanoma; in phase 2 trials); EVX-02 (DNA-based vaccine to treat respected melanoma; completed phase 1 / 2A trials); EVX-03 (DNA-based vaccine for treatment of various cancers, including non-small cell lung cancer). They also have several pre-clinical stage vaccines in the works. Here is why I like it (in addition to the focus on utilizing AI which I think will be the future of biopharma): MERCK! Merck & Co (NYSE: MRK; one of the largest healthcare and pharmaceutical companies in the world) is their strategic partner and investor. - Merck is an investor through its venture investment vehicle (MSD Global Health Innovation Fund). They purchases shares in two private placements (December 2023 and January 2025). - Merck paid EVAX $3.2 million in September 2024 for options to license two vaccine candidates EVX-B2 and EVX-B3. If Merck chooses to exercise the option, they must pay EVAX another $10 million this year (2025), plus EVAX is entitled to development, regulatory, and sales Milestones totaling up to $592 million PER PRODUCT. Plus, EVAX would receive royalties on sales (in addition to the payments mentioned). EVAX is currently trading at a market cap of $19 million. This is essentially nothing relative to the monies they stand to make from the Merck relationship, not to mention their other vaccine candidates. The stock has been beaten down as most biopharma companies are in between PR announcements and prior to announcements of approvals. It is currently trading around $3.00 per share, down from its 52-week high of $17.20, and up from its 52-week low of $1.20. Disclosure: I am a shareholder. My average basis is $1.78. I initially bought shares in early February 2025 after reading about the relationship with Merck and the fact that Merck had just expressed continued believe via their purchase of more shares in late January 2025). My initial purchases were in the high $3’s and up to $4.09 per share. I then continued to buy throughout the market dip this spring. I hold because I believe this will scream upward on any good news announcements and/or via Merck making the next $10 million option payment. I am not a bag holder. I could sell today and make a 67% profit (nearly $50k of profit).

-eShTuPiD

NEON keeps testing 4.30 need to break 4.50. still waiting for a PR

Zestyclose_Ship6486

Every time I see people handwave this off as “PR fluff” I laugh. PR fluff doesn’t involve the DOT, FAA, White House, and United Airlines all in the same sentence

J_Dabson002

Will probably continue to dip to .40 until PR release with crypto treasury details It’s a good long term play but if you’re wanting gains now I’d cut losses

SushinWasabie

Feel your pain , mvst is the no PR compagny, could always go back 2.6 , ill see

J_Dabson002

Rub pulls are easy to spot when you’ve seen enough of them High volume with no prior consolidation? Rug pull Been out of compliance for 9+ months? Rug pull into a r/s No incoming catalyst besides rumors? Rug pull Good PR right beside earnings? Rug pull

Prax150

> 9 years later, Hyperloop has spent millions in research, lobbying and PR, while gaining zero planning permission and not beginning any form of construction. In this same time, China has connected its entire nation with high-speed railway. This is the crazies tone to me. Like we've literally had, for decades, cars that can transport a mass amount of people from one location to another at minimal cost, and people are praising an underground taxi for (I guess?) rich people that is ineffective and overly expensive?

HeftyFineThereFolks

wow were gonna see like a million images of this when he runs for president. great photo op and PR stunt

Grand_Master_Grogu

ATCH $5 easily once earnings come and all the PR is released for the Hanire funding and stock buy back!

Bansionboy

Now we need the treasury PR

Solid_Jackfruit_2932

Really good PR and look at stock price. Pennies are all about market sentiment and looks like I’m right.

J_Dabson002

Just making shit up… The PR was the approval of the crypto treasury

Solid_Jackfruit_2932

Sell before market open this is gonna go down. All the PR is is an approval of the votes, nothing more. Everyone that jumped in expecting crypto treasury announcement is gonna dip once they see it doesn’t move much and this is gonna go back down in the 0.40s

Solid_Jackfruit_2932

PRPH PR is out but there’s no concrete information on shares repurchase or crypto treasury. This is gonna dump market my words

err0rz

1. Auto driving is worst-in-class 2. Most SpaceX (different company btw) contracts in recent years have failed to deliver at huge cost. NASA are currently seeking a new partner. 3. Yes, Grok (again, different company) is worst-in-class LLM with a hilariously bad track record. 4. Starlink (again, different company) is good. Can’t fault this product. 5. Neuralink (again, different company and lol you spelt it wrong) has zero revenue stream and has simply replicated already existing research. 6. Robotaxi has no customer base, is invite only (so no criticism) and has no return on investment in sight 7. You are correct. They are meme holdings on crypto (which is already a meme) 7. Mars Colony is fully scrapped, again after huge investment with no form of return. 8. 9 years later, Hyperloop has spent millions in research, lobbying and PR, while gaining zero planning permission and not beginning any form of construction. In this same time, China has connected its entire nation with high-speed railway. So yes, meme stock. And you just gave a very enjoyable meme opinion.

Solid_Jackfruit_2932

PRPH PR this morning probably

simplyyjohnny

Imagine selling your soul to grift for right, just to have your corpse be a PR stunt for one of the world's most inept morons.

Live_Still_8487

That’s a bullshit company with a shit ton of debts and no revenue and not even single asset in hand!!! They are a PR machine and their CEO is a phony guy!!! Beware!!!

elibutton

This is turning into such a PR spectacle. It's just really sad and disappointing, but not surprised.

fireflymilk

Except there’s no PR or filing by the company…

fireflymilk

There’s no filing or PR from the company.

fireflymilk

$NXTT I see no legitimate filing or PR from them regarding a reverse split. Is the news fake?

AwkwardTraveler

Keep hearing about this PR, but it's a fairy tale until it gets released.

Bansionboy

PR comes out tomorrow, god candle to 15 dollars, he cashes out.

Bansionboy

or PR comes out soon and he sells those warrants after a god candle... definitely not a nothing burger

Bansionboy

PR coming tomorrow AM...?

Primary-Donkey100

The case is waiting for PR about special investors meeting they had on tuesday. We want to know list of approved things. One being crypto treasury.

J_Dabson002

PRPH holding strong and even moving up is a great sign when the PR hasn’t been released yet After hours PR today would make this thing rocket

Solid_Jackfruit_2932

Supposed? Why? People assumed it. They have until Monday to release. They’re not going to rush an important PR the morning after a 4pm meeting because people think it’s best.

asagi_lumina

Love seeing all the bag holders coming back to this thread. If you’ve read my dd i believe i told you regards to wait until the delisting decision is completed, not before, not after. That was the “bet”. Management got tired of seeing their stock going down and finally released a PR and number still looks solid. Read the article, the numbers are there. All we need is for those regards to tell us whether there was fraud or not or if any delisting would happen. so we wait, because this stock is undervalued at the current price. good luck Source: https://finance.yahoo.com/news/pacs-group-announces-nyse-listing-121700238.html

J_Dabson002

The volume is down because the news was not released. That doesn’t change the fact that the price held steady after the lack of PR. Once the PR is released this will move quickly. No reason to sell unless you’re in at sub .40 and the cash elsewhere.

REEMFMetalHead

Yes. The "potential PR" was supposed to be yesterday. That when the volume surged in. Now it's gone. This is all super easy stuff here.

Solid_Jackfruit_2932

So they’ll rush a potential PR the day after the meeting because impatient apes are fomoing?

SPAC_Time

[Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring](https://www.globenewswire.com/news-release/2025/09/11/3148531/0/en/Profusa-Adopts-NVIDIA-Powered-Technology-to-Build-AI-Driven-Insight-Portal-for-Continuous-Biomarker-Monitoring.html) \- PFSA OTC Pink Limited: NVACW PFSA up 190% premarket to 76 cents each after releasing PR announcing "plan to build an AI-fueled, scalable technology backbone" using "the industry leading NVIDIA NeMo hardware and software stack".

Primary-Donkey100

PRPH, no PR in pre-market. Going to sell this one.

Primary-Donkey100

Let me add that I am certain they will publish PR about it, but I just don’t know when. Ideal time was on wednesday pre-market but maybe we’ll get it this week

Primary-Donkey100

PR is still possible but idk if it gets same hype again. I really hope for PR today before market opens.

Primary-Donkey100

People sold because everyone expected to get PR about special investors meeting they had. It’s hype play so it loses momentum without news that would drive the price up again.

birdflustocks

Overall there are limitations to how much societies and individuals are willing to pay and what the burden of seasonal influenza is. Influenza vaccines are generally quite affordable but uptake relies on policies. Individual demand declines significantly as soon as any inconveniences or payments are involved. Many countries have very low influenza vaccination rates and the USA as largest market is subject to healthcare cuts and pro-disease policies that some call eugenics. There are also demands for lower pharmaceutical prices or worldwide uniform prices. I think CD388 has a lot of potential but the price per dose you calculate with comes with significant limitations. It may be a starting point and captivate analysts, but in my opinion the strength of a long-lasting universal influenza drug would be large rotating stockpiles and that requires much lower prices. Overall the public appearance is very conventional. Everything is outsourced to a large PR agency and there is no internal marketing expertise. You can get all the data from my analysis on Substack (can't link here) from last year. There is also great content on SeekingAlpha but they won't publish any thesis regarding stockpiles until there is definitive shelf-life data. u/Sashamirae17 mentions phase 3, approval and commercialization risks. I think that is a relevant answer. Many investors will shy away from a biotech company with no revenue that depends on a single drug in development. But personally I don't worry about that at all.

KRAFT_MAY0

still got to throw in ATCH! staying in its channel and any PR is going to cause this ticker to skyrocket!

ThrowRA91041

Look guys, PRPH aren’t publishing PR this week. The stock will fall off the cliff.

Xtianus21

Thought for 2m 27s Got it—here’s a **BS check** on that reply, fast and surgical: * **“Your MW numbers came from nowhere.” → Wrong.** **CRWV** ended Q2 with **\~470 MW** and says it’s on track for **>900 MW by YE’25** (company transcript). Q4 Capital **NBIS** publicly guides **\~100 MW in 2025** (Vineland phase 1) and **targets \~1 GW by end-2026** (IR/news). Data Center DynamicsNebiusReuters * **“Use EV/NTM, P/ARR is unsound.” → Overstated.** P/ARR is **non-standard** and ignores capital structure—but it’s not “invalid” if used consistently. EV/NTM Revenue is cleaner; calling P/ARR “unsound” is rhetoric, not a factual error. * **“NBIS is 11.35× TEV/NTM vs CRWV 9.97× (CapIQ).” → Unsupported as stated.** Could be true, but it’s **uncited** and depends on **proprietary estimates**; no public source given. If you want to use it, **show the inputs** (NTM rev, net debt, options). No source = hand-wave. * **“CRWV interest $260m vs NBIS $4.6m proves your multiple is bad.” → Partly right, partly spin.** Facts: **CRWV Q2 interest expense = \~$267m** (company), and NBIS shows **\~$4.8m** in its Q2 release tables. Those numbers are real; the leap to “P/ARR is bogus” is **opinion**. Q4 CapitalBusiness Wire * **“$105.1m is NBIS group revenue—you mislabel it as cloud.” → Fair.** NBIS’s **Q2 $105.1m** is **group** revenue; the release does **not** break out “cloud only.” Your earlier wording should say **“group”**, with AI infra as the growth driver. [Nebius](https://nebius.com/newsroom/nebius-reports-second-quarter-financial-results-and-raises-arr-guidance-for-2025?utm_source=chatgpt.com) * **“GS report says Finland triples, UK cluster, co-los (KS/IS/Paris), 1 GW by ’26.” → Directionally right, not unique to GS.** Public NBIS sources already say **Finland → 75 MW**, **UK Blackwell cluster live Q4’25**, **Kansas/Iceland/Paris co-los**, and **1 GW by 2026**. Nothing here debunks your capacity-gating thesis. Nebius+4Nebius+4Nebius+4 * **“NBIS is 20% more power-efficient from custom racks.” → Marketing claim, not a hard audited fact.** NBIS cites **\~20% lower TCO/energy** in PR/sustainability materials; treat as **company claim**, not an independent benchmark. **Net:** They landed a fair hit on your **“cloud vs group”** label and (reasonably) prefer **EV/NTM** over **P/ARR**. But calling your MW math “made up” is **just wrong**—both companies’ capacity roadmaps are on-record, and your **capacity-gated revenue** point still stands.

Travel-Management

I’m not buying unless the next PR says they’re launching a blockchain-powered forklift too

Senior-Purchase-538

Todays PR confirms my suspicions about Microsoft or Aws being the first anchor tenant. With carbon capture tech from context labs, there's no doubt in my mind the hyperscaler is Microsoft. https://contextlabs.com/ Now we need DAs and PPA, Microsoft to step out of the shadows. LOIs to definitives. Everything lining up beautifully imo. It's either 50x or a complete bust. But to me.. last couple of months developments been fundamentally huge.. since June/July. Delist threat is just temporary noise... But it all depends on PPA signed and LOIs turning to definitives... next couple of 6-7 months will be crucial as they will present their plan for compliance at upcoming hearing and probably get another 180 days to regain compliance.

DeepestWinterBlue

You know the reality doesn’t matter it’s the perception and the PR and buyer sentiment that will get a stock to moon.

Fun_Ball_8238

It’s actually pretty common, the person who just told us it’ll be at 8:00 exact didn’t really look back to see sometimes they have very random times they post PR’s.

Solid_Jackfruit_2932

I mean people assumed PR was gonna be this morning. Pretty sure company never said that. Could be tomorrow or in a few days for all we know

Primary-Donkey100

No PR from PRPH. I expect a red day